METTL3 and breast carcinoma: The only studies of breast cancer have shown that METTL3-mediated enhancement of m6A level could promote the proliferation of breast cancer cells (10), while the high level of m6A caused by FTO knockdown could inhibit the proliferation and metastasis of breast cancer (11).